50 and older, any sex, with Cancer, Advanced or Cognitive Impairment, Mild. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Proportion of Dyads That Complete the StudyPrimary· week 14
The number of participants that complete the entire study procedures out of the number of participants enrolled in the study. The study consisted of one patient and one caregiver (defined as a dyad) that completed the study procedures together), therefore there were 19 dyads enrolled in the study or 38 participants. The proportion of participants that completed the study was determined out of the 19 dyads enrolled.
Group
Value
95% CI
Cancer Patients
12
Proportion of Participants That Consent Who Are Approached for the StudyPrimary· Baseline
The number of participants who consented for the study out of the number of eligible participants who were approached and asked if they would like to be in the study. This outcome measures the proportion of potential participants approached who provided informed consent to participate in the Dyadic Life Review (DLR) study. A total of 42 patients were approached, and 38 provided informed consent to participate.The proportion was calculated as the number who consented divided by the total number approached (38 ÷ 42 × 100 = 90.5 percent).
Group
Value
95% CI
DLR Intervention
38
Number of Participants Who State the Intervention is Acceptable During a Qualitative InterviewPrimary· week 14
The proportion of participants who completed the full study intervention and indicated that the intervention was acceptable during post-intervention qualitative interviews. Acceptability was assessed only among participants who completed all study sessions.
Group
Value
95% CI
DLR Intervention
12
Mean Change in the UCLA Loneliness Score for CaregiversSecondary· baseline to week 14
UCLA Loneliness Scale assesses perceived loneliness on a 0-10 scale, with higher scores indicating greater loneliness. Mean change was calculated as week 14 score minus baseline score for caregivers who completed the measure.
Group
Value
95% CI
DLR Intervention
0.64
± 4.97
Mean Change in Unidimensional Relationship Closeness Scale for CaregiversSecondary· baseline to week 14
This measures the quality of the relationship with the care-receiver: assesses quality of relationship between participant and family member and has demonstrated valid scores across several relationship types, including spouses and other family members. The scale of this instrument ranges from 1 to 7 with higher scores indicating more closeness. The change in score pre and post intervention was determined by subtracting the post intervention score from the pre intervention score and the mean of the change scores was calculated.
Group
Value
95% CI
DLR Intervention
-0.05
± 0.7
Mean Change in Perceived Stress Scale for CaregiversSecondary· baseline to week 14
Measures perceived stress, scale 0-40, higher scores indicate greater stress. Mean change calculated as week 14 minus baseline for caregivers who completed the measure.
Group
Value
95% CI
DLR Intervention
-0.17
± 2.08
Mean Change in Caregiver Reaction Scale for CaregiversSecondary· baseline to week 14
Items assess both positive and negative aspects of caregiving. Subscales: role captivity, overload, relational deprivation, competence, personal gain, family beliefs, family conflict, job conflict. The scale ranges from 0 to 24 with higher scores indicating a more negative caregiver experience. Preliminary evidence for the validity and reliability of the Caregiver Reaction Scale. Mean change calculated as week 14 minus baseline for caregivers who completed the measure.
Group
Value
95% CI
DLR Intervention
-0.42
± 2.07
Mean Change in Geriatric Depression Scale for CaregiversSecondary· baseline to week 14
The purpose of this scale is to identify the clinical threshold of depression in older adults. The scale ranges from 0 to 15 with higher scores indicating worse depression. The change in score pre and post intervention was determined by subtracting the post intervention score from the pre intervention score and the mean of the change scores was calculated. Mean change calculated as week 14 minus baseline for caregivers who completed the measure.
Group
Value
95% CI
DLR Intervention
1.33
± 2.53
Mean Change in Distress Thermometer and Problem List for CaregiversSecondary· baseline to week 14
This tool is a 10-point self-report measure to capture distress and identify a list of sources of that distress. The scale ranges from 0-10 with higher scores indicating more distress. Mean change calculated as week 14 minus baseline for caregivers who completed the measure.
Group
Value
95% CI
DLR Intervention
-0.42
± 2.43
Mean Change in Dyadic Adjustment Scale-7 for CaregiversSecondary· baseline to week 14
This is a 7-item measure to assess relationship quality that ranges from 0-36 with higher scores indicating positive relationship quality. The change in score pre and post intervention was determined by subtracting the post intervention score from the pre intervention score and the mean of the change scores was calculated.
Group
Value
95% CI
DLR Intervention
1.17
± 3.93
Mean Change in Dyadic Support Questionnaire For CaregiversSecondary· baseline to week 14
18-item measure assessing perceived received and provided support. Scale 0-145, higher scores indicate better dyadic coping. Mean change calculated as week 14 minus baseline for caregivers who completed the measure.
Group
Value
95% CI
DLR Intervention
1.83
± 6.56
Mean Change in the Correlation Between Patient and Caregiver DistressSecondary· baseline to week 14
Distress measured using Distress Thermometer (0-10, higher = more distress). Pearson correlation coefficient between patient and caregiver distress scores calculated at baseline and week 14; mean change = week 14 minus baseline.
Group
Value
95% CI
DLR Intervention
-0.64
± 0.05
Sponsor's own description
The purpose of this study is to test the feasibility of a telehealth Dyadic Life Review (DLR), adapted from individual Life Review Therapy, with patients and caregivers of older adults with advanced cancer, including those with also Mild Cognitive Impairment (MCI). The study will enroll aim to enroll 20 dyads (pairs) of patients and caregivers (40 total subjects).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT03383094 — Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer
· Phase 2
· active not recruiting
Other University of Rochester trials
Trials by the same sponsor.
NCT07075965 — Calcium Channel Blocker in Myotonic Dystrophy Type 1
· Phase 1
· not yet recruiting
NCT07423104 — A Study of Cladribine, Low Dose Cytarabine, and Venetoclax in Treatment of Relapsed/Refractory or Secondary Acute Myeloi
· Phase 2
· not yet recruiting
NCT05744869 — SBAT for Health Equity
· NA
· not yet recruiting
NCT06052956 — Efficacy of Methylene Blue Photodynamic Therapy for Treatment of Deep Tissue Abscesses
· Phase 2
· not yet recruiting
NCT07032636 — Reducing Crises and Suicide Within the Idaho Army National Guard
· NA
· not yet recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Rochester
Last refreshed: 25 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05200572.